EDTA chelation is a therapy by which constant administrations of a fragile synthetic amino acid (EDTA, ethylenediamine tetra-acetic acid) related to vinegar steadily reduce atherosclerotic plaque and other mineral deposits throughout the cardiovascular system by literally dissolving them away. For the most ordinary forms of heavy metal intoxication, those concerning lead, arsenic or mercury, the standard of care in the US dictates the use of DMSA. In the 1940s and 50s, several doctors using EDTA to treat lead toxicity in patients who also happened to experience from heart disease observed an unexpected progress in their angina symptoms. Since that time, doctors have used EDTA to treat blood vessels diseases, based on their faith from observing individual patients and on other types of evidence, that EDTA is useful for that purpose.

Chelation therapy is a method involving the utilization of chelating agents to remove heavy metals from the body. Heavy metals such as lead have a bigger affinity for EDTA and form stronger bonds. In both case, it is essential that there is enough of the compound known as cysteine in the formula. In medicine, chelation has been logically proven to rid the body of excess or toxic metals. For example, a person who has lead poisoning may be given chelation therapy in order to bind and get rid of excess lead from the body before it can cause damage. In an 18-year study, Dr. Walter Blumer of Switzerland used EDTA chelation to decrease the incidence of heart disease and cancer in his patients by 80 percent. EDTA chelation offers a answer for reversing osteoporosis or bone loss. Through a complex action of the parathyroid gland, EDTA actually stimulates bone growth. Thus, while it’s removing calcium from plaque in blood vessels, EDTA has the capacity to make bones stronger and denser. Women have reported the reversal of bone loss in as little as two months using EDTA chelation.